Cancer organizations are urging researchers, oncologists, and other stakeholders to advocate for cancer research.

1. HX044: A first-in-class (FIC) CTLA-4xSIRPα is a bispecific antibody fusion protein designed to enhance safety and amplify anti-tumor immunity. HX044 targets PD-1-resistant solid tumors (e.g ...

Purple Biotech presented promising NT219 data as a potential biomarker for colorectal cancer treatment at AACR 2025. Quiver AI Summary. Purple Biotech Ltd. has announced promising new data ...

Y-mAbs presented preclinical PK data for CD38-SADA at the 2025 AACR Annual Meeting, supporting its cancer ... indicating progress in bringing ... in the Company’s Annual Report on Form 10-K ...

Vaccinex to Report Promising New ... benefit in patients with melanoma and head and neck cancer at the 2025 Annual Meeting of American Association for Cancer Research (AACR ... will progress.

Tempest Announces Amezalpat Poster Presentation at the 2025 American Association for Cancer Research (AACR) Annual Meeting Provided by GlobeNewswire Mar 25, 2025 8:30pm ...

More than 5% of all cancer cases are caused by drinking alcohol, according to the Cancer Progress Report 2024 from the American Association for Cancer Research (AACR).

According to the AACR report, the age-adjusted overall cancer death rate in the US fell by 33% between 1991 and 2021, meaning about 4.1 million cancer deaths were averted.

The American Association for Cancer Research (AACR) published its 2024 Cancer Progress Report on Sept. 18, highlighting a strong link between alcohol use and six types of cancer. This comes as the ...